December 2nd 2024
Your daily dose of the clinical news you may have missed.
November 27th 2024
A woman in her early 50s presents with 6 hours of right sided pleuritic chest pain. What do the history and ECG suggest? What's yoru Dx?
November 26th 2024
The patient shows no signs of trauma but is a poor historian so no further details are available. Do her vitals or ECG provide any clues to a Dx?
November 25th 2024
November 22nd 2024
Daily Dose: Bempedoic Acid Linked to 20% Reduction in Total CV Events
Daily Dose: Childhood Stress & Risk for Cardiometabolic Disease
Diabetes Remission of Any Duration May Reduce Risk of Renal and Cardiovascular Disease:
Remission of T2D, regardless of duration of remission, was associated with reduced risk of diabetes-related CKD and CVD in a post hoc analysis of Look AHEAD.
Bempedoic Acid Associated with 20% Reduction in Total CV Events in Prespecified CLEAR Outcomes Analysis
The protective effect of bempedoic acid appeared to increase with the number of CV events a study participant experienced, according to study authors.
More Childhood Stress Linked to Increased Risk for Cardiometabolic Disease
Findings from new study suggest that promoting healthy coping strategies for stress during early life can reduce cardiometabolic risk, report researchers.
Consuming More Food, Beverages with Added Sugar Linked to Greater Risk for Metabolic Syndrome
Compared to the lowest intake of AS-rich food and beverages, the highest intake was associated with a 59% higher risk of developing MetS, according to new findings.
COPD Exacerbations May Increase Risk of Severe CV Events by More Than 15-Fold: Cohort Study
The risk of severe CV events, including leading to death, was greatest in the first week following an exacerbation but remained significantly elevated 1 year later.
Eli Lilly Open Letter Warns Against Use of Tirzepatide for "Cosmetic Weight Loss"
In an open letter to the public, Lilly decries use of tirzepatide products Mounjaro and Zepbound for nonmedical purposes and warns of counterfeit formulations.
Statin Use May Reduce VTE Risk in Perimenopausal Women Taking Exogenous Hormones
While not eliminated, study authors found risk of VTE reduced roughly by half in women taking vs not taking a statin when initiating hormone therapy.
Daily Dose: Menstrual Disorders Raise Risk for Future CVD in Young Women
FDA Updates LDL-C Lowering Indication for Bempedoic Acid, Bempedoic Acid plus Ezetimibe Tablets
The US FDA approved expanded indications for bempedoic acid and bempedoic acid plus ezetimibe for primary hyperlipidemia.
Daily Dose: Omega-3 Fatty Acids Reduce CVD Risk in Individuals with Family History of CVD
Daily Dose: Vegan Diet Linked to Better Cardiovascular Health
Daily Dose: Eligible Adults Lack Statin Prevention for ASCVD
New Data Show Omega-3 Polyunsaturated Fatty Acids Lower CVD Risk in Persons with Family History of CVD
Higher intake of omega-3 polyunsaturated fatty acids may reduce the risk for cardiovascular disease in persons with a family history of CVD.
Daily Dose: Extended Use of ADHD Drugs Linked to Higher CVD Risk
Vegan Diet Linked to Better Cardiovascular Health in New Study of Identical Twins
Twins randomly assigned to a plant-based diet had significant decreases in LDL-C concentration, fasting insulin levels, and body weight.
Most Eligible Adults are Not Receiving Statins for Primary Prevention of ASCVD, Shows New Study
Statin use remained at only 35% among eligible adults since updated guidelines from ACC/AHA on cholesterol treatment.
10 Take-Home Messages from the New ACC/AHA Atrial Fibrillation Guidelines: A Guideline Topline
The 10 most important take-homes from the 2023 ACC/AHA AF guidelines are summarized in this Guideline Topline, an at-a-glance preview for primary care.
Daily Dose: Cardiovascular Risk Factors Rising Among Middle-Aged Americans
Longer Use of ADHD Medications Linked to Higher Risk of CVD in Recent Study
The risk of cardiovascular disease increased with longer cumulative exposure to ADHD medications, peaking at 3 to 5 years of use, reported researchers.
10 Top Studies from The Liver Meeting 2023: At-a-Glance
Simplified risk stratification tools for NAFLD, effects of statins on hepatic disease, trends in OHE, and patient perspectives are samples of the noteworthy research areas.
Updated Guidelines for Atrial Fibrillation from ACC/AHA Focus on Aggressive Prevention and Control and a Continuum of Care
The revised guidance classifies AF into 4 stages, emphasizes prevention and aggressive rhythm control, and upgrades recommendations for catheter ablation and LAA occlusion.
Migraine & Hypertension: What is the Connection?
Which antihypertensive therapy options are most and least effective for patients with migraine? Get details, here.
Risk Stratification for Preeclampsia Would Save Lives, Reduce Burden of Cost to Health Care System
Identifying women at risk for preeclampsia with severe features and the most effective treatment is essential to reduce morbidity as well as to contain costs.
Daily Dose: COVID-19, Opioid Epidemic Primary Drivers of Widening Gender Gap in Life Expectancy
Primary Prevention of ASCVD: A Guideline Topline for Primary Care
Review the ACC/AHA guidelines on prevention of ASCVD through lifestyle and risk factor assessment and management in our at-a-glance slide show.
CV Risk Factors Increasing Among Middle-Aged US Adults, Socioeconomic Inequities Persist: New Findings
Cardiovascular mortality has been increasing among middle-aged US adult since 2011; a new study looked at changes in CV risk factors by income level over the past 20 years.
Daily Dose: Lowering SBP to <120 mm Hg Reduces CV Event Risk
How to Build Assessment for Cardiovascular-Kidney-Metabolic Syndrome into Primary CVD Prevention
Chiadi Ndumele, MD, PhD, MHS, offers 3 thoughts for primary care on incorporating CKM syndrome screening into daily clinical practice.